Tiansheng Pharmaceutical Group Co., Ltd.

¥6.21As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002872Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (16.11%)
Div yield —
ROE (2.83%)
Biotechnology
Beta (5Y) 0.43
PE TTM —
TSR TTM 20.82%
Mkt cap ¥1.975B
ROIC (3.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.96
12.15%
30.13%
Hold 3|2|8|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.06
0.06
0.06
3.98%
3.09%
3.33%
11.74%
Revenue¥M
231.6
235.2
247.8
257.3
15.60%
11.15%
11.55%
11.05%
Peers (US$296.0M)
Cap (US$)
PE
301.1M
76.93x
Capital
TTM
5Y
10Y
Leveragex
3.133
—
—
EBIT/Intx
0.087
1.015
0.919
Own earn%
(39.16)
15.99
37.70
Sh yield%
28.94
29.82
27.86
Owners
Insiders/Inst%
8.87
22.42
Short interest%
1.86
SBC / revenue%
2.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
31–36
$1 testx
0.9
Incr. ROIC%
32